KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) Equity Average (2016 - 2026)

Chemed filings provide 17 years of Equity Average readings, the most recent being $913.7 million for Q1 2026.

  • For the quarter ending Q1 2026, Equity Average fell 20.57% year-over-year to $913.7 million, compared with a TTM value of $913.7 million through Mar 2026, down 20.57%, and an annual FY2025 reading of $1.0 billion, down 5.77% over the prior year.
  • Equity Average hit $913.7 million in Q1 2026 for Chemed, down from $1.0 billion in the prior quarter.
  • The five-year high for Equity Average was $1.2 billion in Q3 2024, with the low at $645.0 million in Q1 2022.
  • Median Equity Average over the past 5 years was $1.0 billion (2025), compared with a mean of $985.2 million.
  • The sharpest move saw Equity Average fell 29.51% in 2022, then surged 40.17% in 2023.
  • Year by year, Equity Average stood at $760.1 million in 2022, then soared by 39.93% to $1.1 billion in 2023, then increased by 10.7% to $1.2 billion in 2024, then fell by 12.68% to $1.0 billion in 2025, then fell by 11.12% to $913.7 million in 2026.
  • According to Business Quant data, Equity Average over the past three periods came in at $913.7 million, $1.0 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.